Biokarpet S.A. (ATH: BIOKA)
Greece
· Delayed Price · Currency is EUR 1.865
-0.005 (-0.27%)
Dec 20, 2024, 5:18 PM EET
Biokarpet Income Statement
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Revenue | 197.2 | 209.99 | 231.22 | 187.29 | 123.24 | 125.75 | Upgrade
|
| Revenue Growth (YoY) | -9.58% | -9.18% | 23.46% | 51.97% | -2.00% | 5.31% | Upgrade
|
| Cost of Revenue | 165.53 | 174.48 | 189.6 | 155.81 | 99.5 | 100.81 | Upgrade
|
| Gross Profit | 31.67 | 35.51 | 41.63 | 31.48 | 23.74 | 24.94 | Upgrade
|
| Selling, General & Admin | 27.86 | 27.5 | 27.95 | 23.62 | 20.3 | 19.99 | Upgrade
|
| Research & Development | 0.41 | 0.58 | 0.5 | 0.58 | 0.42 | 0.41 | Upgrade
|
| Other Operating Expenses | -3.42 | -0.95 | -0.28 | -0.42 | -0.44 | -0.01 | Upgrade
|
| Operating Expenses | 24.86 | 27.14 | 28.16 | 23.77 | 20.28 | 20.38 | Upgrade
|
| Operating Income | 6.81 | 8.38 | 13.47 | 7.7 | 3.46 | 4.55 | Upgrade
|
| Interest Expense | -6.93 | -6.75 | -3.89 | -3.12 | -2.88 | -2.68 | Upgrade
|
| Interest & Investment Income | 0 | 0 | 0 | 0.01 | 0.06 | 0 | Upgrade
|
| Currency Exchange Gain (Loss) | 0.02 | 0.02 | 0.1 | 0 | 0.07 | 0.02 | Upgrade
|
| Other Non Operating Income (Expenses) | 0.17 | 0.12 | -0.1 | -0.36 | -0.34 | -0.35 | Upgrade
|
| EBT Excluding Unusual Items | 0.42 | 1.77 | 9.57 | 4.23 | 0.38 | 1.54 | Upgrade
|
| Gain (Loss) on Sale of Investments | 0.01 | 0.05 | -0 | -0.03 | -0.15 | 0.44 | Upgrade
|
| Gain (Loss) on Sale of Assets | -0.27 | -0.27 | 1.27 | 0.82 | 0.51 | -0.02 | Upgrade
|
| Pretax Income | 4.89 | 6.28 | 10.84 | 5.02 | 0.73 | 1.96 | Upgrade
|
| Income Tax Expense | 1.49 | 0.69 | 1.7 | 0.76 | 0.51 | 0.68 | Upgrade
|
| Earnings From Continuing Operations | 3.41 | 5.58 | 9.13 | 4.26 | 0.22 | 1.27 | Upgrade
|
| Minority Interest in Earnings | -0.07 | -0.09 | -0.14 | -0.06 | -0.02 | -0.03 | Upgrade
|
| Net Income | 3.34 | 5.49 | 8.99 | 4.21 | 0.2 | 1.24 | Upgrade
|
| Net Income to Common | 3.34 | 5.49 | 8.99 | 4.21 | 0.2 | 1.24 | Upgrade
|
| Net Income Growth | -20.38% | -38.94% | 113.87% | 1971.19% | -83.62% | 626.25% | Upgrade
|
| Shares Outstanding (Basic) | 24 | 24 | 24 | 24 | 24 | 24 | Upgrade
|
| Shares Outstanding (Diluted) | 24 | 24 | 24 | 24 | 24 | 24 | Upgrade
|
| EPS (Basic) | 0.14 | 0.23 | 0.37 | 0.18 | 0.01 | 0.05 | Upgrade
|
| EPS (Diluted) | 0.14 | 0.23 | 0.37 | 0.18 | 0.01 | 0.05 | Upgrade
|
| EPS Growth | -20.38% | -38.94% | 113.87% | 1971.31% | -83.62% | 626.27% | Upgrade
|
| Free Cash Flow | -12.98 | -0.66 | -5.74 | -3.26 | -13.54 | 2.54 | Upgrade
|
| Free Cash Flow Per Share | -0.54 | -0.03 | -0.24 | -0.14 | -0.56 | 0.11 | Upgrade
|
| Gross Margin | 16.06% | 16.91% | 18.00% | 16.81% | 19.26% | 19.83% | Upgrade
|
| Operating Margin | 3.46% | 3.99% | 5.82% | 4.11% | 2.81% | 3.62% | Upgrade
|
| Profit Margin | 1.69% | 2.62% | 3.89% | 2.25% | 0.16% | 0.99% | Upgrade
|
| Free Cash Flow Margin | -6.58% | -0.31% | -2.48% | -1.74% | -10.99% | 2.02% | Upgrade
|
| EBITDA | 11.45 | 13.6 | 17.97 | 12.08 | 7.49 | 8.05 | Upgrade
|
| EBITDA Margin | 5.80% | 6.48% | 7.77% | 6.45% | 6.08% | 6.40% | Upgrade
|
| D&A For EBITDA | 4.63 | 5.22 | 4.5 | 4.37 | 4.02 | 3.49 | Upgrade
|
| EBIT | 6.81 | 8.38 | 13.47 | 7.7 | 3.46 | 4.55 | Upgrade
|
| EBIT Margin | 3.46% | 3.99% | 5.82% | 4.11% | 2.81% | 3.62% | Upgrade
|
| Effective Tax Rate | 30.39% | 11.02% | 15.73% | 15.05% | 70.02% | 34.94% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.